{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:18:37Z","timestamp":1792592317527,"version":"4.5.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Dyskeratosis congenita (DC) is a multisystem inherited syndrome exhibiting marked clinical and genetic heterogeneity. In its classic form, it is characterized by mucocutaneous abnormalities, BM failure, and a predisposition to cancer. BM failure is the principal cause of premature mortality. Studies over the last 15 years have led to significant advances, with 8 DC genes (DKC1, TERC, TERT, NOP10, NHP2, TIN2, C16orf57, and TCAB1) having been characterized. Seven of these are important in telomere maintenance either because they encode components of the telomerase enzyme complex (DKC1, TERC, TERT, NOP10, NHP2, and TCAB1) or the shelterin complex (TINF2). DC is therefore principally a disease of defective telomere maintenance and patients usually have very short telomeres. The genetic advances have led to the unification of DC with several other disorders, including the severe multisystem disorders Hoyeraal-Hreidarsson and Revesz syndromes, as well as a subset of patients with aplastic anemia, myelodysplasia, leukemia, and idiopathic pulmonary fibrosis. This wide spectrum of diseases ranging from classic DC to aplastic anemia can be regarded as disorders of defective telomere maintenance\u2014\u201cthe telomereopathies.\u201d These advances have increased our understanding of normal hematopoiesis and highlighted the important role of telomerase and telomeres in human biology. They are also facilitating the diagnosis (especially when presentation is atypical) and management of DC.<\/jats:p>","DOI":"10.1182\/asheducation-2011.1.480","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T20:33:13Z","timestamp":1323289993000},"page":"480-486","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":250,"title":["Dyskeratosis Congenita"],"prefix":"10.1182","volume":"2011","author":[{"given":"Inderjeet","family":"Dokal","sequence":"first","affiliation":[{"name":"Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111716381743800_B1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111716381743800_B2","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.febslet.2010.05.019","article-title":"Dyskeratosis congenita","volume":"584","author":"Bessler","year":"2010","journal-title":"FEBS Lett"},{"key":"2019111716381743800_B3","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","article-title":"Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation","volume":"107","author":"Vulliamy","year":"2006","journal-title":"Blood"},{"key":"2019111716381743800_B4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"key":"2019111716381743800_B5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1651-2227.1970.tb08986.x","article-title":"Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers","volume":"59","author":"Hoyeraal","year":"1970","journal-title":"Acta Paediatr Scand"},{"key":"2019111716381743800_B6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2141.1999.01690.x","article-title":"Unexplained aplastic anaemia, immunodeficiency and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) is caused by mutations in the DKC1 gene","volume":"107","author":"Knight","year":"1999","journal-title":"Br J Haematol"},{"key":"2019111716381743800_B7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/35096585","article-title":"The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita","volume":"413","author":"Vulliamy","year":"2001","journal-title":"Nature"},{"key":"2019111716381743800_B8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nchembio.2007.38","article-title":"Telomere length, stem cells and aging","volume":"3","author":"Blasco","year":"2007","journal-title":"Nat Chem Biol"},{"key":"2019111716381743800_B9","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(02)09087-6","article-title":"Association between aplastic anaemia and mutations in telomerase RNA","volume":"359","author":"Vulliamy","year":"2002","journal-title":"Lancet"},{"key":"2019111716381743800_B10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2003-01-0335","article-title":"Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome","volume":"102","author":"Yamaguchi","year":"2003","journal-title":"Blood"},{"key":"2019111716381743800_B11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1126\/science.1138596","article-title":"Protein composition of catalytically active human telomerase from immortal cells","volume":"315","author":"Cohen","year":"2007","journal-title":"Science"},{"key":"2019111716381743800_B12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bcmd.2004.12.008","article-title":"Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure","volume":"34","author":"Vulliamy","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"2019111716381743800_B13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111716381743800_B14","doi-asserted-by":"crossref","first-page":"e10680.5","DOI":"10.1371\/journal.pone.0010680","article-title":"Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations","volume":"5","author":"Diaz de Leon","year":"2010","journal-title":"PLoS One"},{"key":"2019111716381743800_B15","doi-asserted-by":"crossref","first-page":"e7926","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations","volume":"4","author":"Calado","year":"2009","journal-title":"PLoS One"},{"key":"2019111716381743800_B16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1073\/pnas.0807057106","article-title":"Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia","volume":"106","author":"Calado","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111716381743800_B17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/humu.21115","article-title":"Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukaemia","volume":"30","author":"Kirwan","year":"2009","journal-title":"Hum Mutat"},{"key":"2019111716381743800_B18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev"},{"key":"2019111716381743800_B19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2019111716381743800_B20","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood-2008-05-153445","article-title":"TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes","volume":"112","author":"Walne","year":"2008","journal-title":"Blood"},{"key":"2019111716381743800_B21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.29.9.673","article-title":"Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome?","volume":"29","author":"Revesz","year":"1992","journal-title":"J Med Genet"},{"key":"2019111716381743800_B22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1346","article-title":"Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC","volume":"36","author":"Vulliamy","year":"2004","journal-title":"Nat Genet"},{"key":"2019111716381743800_B23","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1073\/pnas.0508124102","article-title":"Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita","volume":"102","author":"Armanios","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111716381743800_B24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/hmg\/ddm111","article-title":"Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase associated protein NOP10","volume":"16","author":"Walne","year":"2007","journal-title":"Hum Mol Genet"},{"key":"2019111716381743800_B25","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2006-12-062851","article-title":"Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome","volume":"110","author":"Marrone","year":"2007","journal-title":"Blood"},{"key":"2019111716381743800_B26","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1073\/pnas.0800042105","article-title":"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita","volume":"105","author":"Vulliamy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111716381743800_B27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tibs.2006.04.002","article-title":"How a single protein complex accommodates many different H\/ACA RNAs","volume":"31","author":"Meier","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"2019111716381743800_B28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1101\/gad.2006411","article-title":"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita","volume":"25","author":"Zhong","year":"2011","journal-title":"Genes Dev"},{"key":"2019111716381743800_B29","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1093\/hmg\/ddq371","article-title":"Mutations in C16orf57 and normal length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome","volume":"19","author":"Walne","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2019111716381743800_B30","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1182\/blood.V79.12.3138.3138","article-title":"\u201cStem cell\u201d origin of the hematopoietic defect in dyskeratosis congenita","volume":"79","author":"Marsh","year":"1992","journal-title":"Blood"},{"key":"2019111716381743800_B31","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1182\/blood-2007-10-120204","article-title":"Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita","volume":"111","author":"Goldman","year":"2008","journal-title":"Blood"},{"key":"2019111716381743800_B32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"key":"2019111716381743800_B33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/bcmd.2001.0389","article-title":"Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita","volume":"27","author":"Vulliamy","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"2019111716381743800_B34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"key":"2019111716381743800_B35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2008-07-166421","article-title":"TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements","volume":"113","author":"Du","year":"2009","journal-title":"Blood"},{"key":"2019111716381743800_B36","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"2019111716381743800_B37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","article-title":"Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation","volume":"11","author":"de la Fuente","year":"2007","journal-title":"Pediatr Transplant"},{"key":"2019111716381743800_B38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111716381743800_B39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2141.2008.07516.x","article-title":"Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients","volume":"144","author":"Kirwan","year":"2009","journal-title":"Br J Haematol"},{"key":"2019111716381743800_B40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature08792","article-title":"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients","volume":"464","author":"Agarwal","year":"2010","journal-title":"Nature"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/480\/1493144\/bep00111000480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/480\/1493144\/bep00111000480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T21:38:32Z","timestamp":1574026712000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2011\/1\/480\/96431\/Dyskeratosis-Congenita"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2011.1.480","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]}}}